Wells Fargo & Company Evolus, Inc. Call Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Call Options
2 transactions
Others Institutions Holding EOLS
# of Institutions
165Shares Held
49.3MCall Options Held
453KPut Options Held
14K-
Perceptive Advisors LLC New York, NY5.75MShares$82.2 Million1.81% of portfolio
-
Tang Capital Management LLC San Diego, CA4.85MShares$69.3 Million6.42% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$57.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.99MShares$42.7 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.91MShares$41.6 Million2.11% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $802M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...